Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop

ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to... Ann Surg Oncol (2022) 29:6369 https://doi.org/10.1245/s10434-022-12214-8 ASO VISUAL ABSTRACT ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop 1 2 1 3 Corey K. Gentle, MD , Hemasat Alkhatib, MD , Stephanie A. Valente, DO, FACS , Chao Tu, MS , and Debra A. Pratt, MD, FACS 1 2 Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, OH; Department of Surgery, MetroHealth, Cleveland, OH; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH In a review of metastatic non-breast cancer (https://doi. and subsequent workup revealed no primary breast cancers. org/10.1245/s10434-022-12132-9), 14% of women under- Women with metastatic cancer should not be screened for went screening mammography after stage IV diagnosis, breast cancer given lack of benefit. FUNDING No external sources of funding. DISCLOSURES There are no conflicts of interest to report for any of the authors. Society of Surgical Oncology 2022 Published Online: 2 August 2022 Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. D. A. Pratt, MD, FACS e-mail: deprat@ccf.org http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop

ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop

Abstract

Ann Surg Oncol (2022) 29:6369 https://doi.org/10.1245/s10434-022-12214-8 ASO VISUAL ABSTRACT ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop 1 2 1 3 Corey K. Gentle, MD , Hemasat Alkhatib, MD , Stephanie A. Valente, DO, FACS , Chao Tu, MS , and Debra A. Pratt, MD, FACS 1 2 Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, OH; Department of Surgery, MetroHealth, Cleveland, OH; Department of...
Loading next page...
 
/lp/springer-journals/aso-visual-abstract-stage-iv-non-breast-cancer-patients-and-screening-uDydcC80SR

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © Society of Surgical Oncology 2022
ISSN
1068-9265
eISSN
1534-4681
DOI
10.1245/s10434-022-12214-8
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2022) 29:6369 https://doi.org/10.1245/s10434-022-12214-8 ASO VISUAL ABSTRACT ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop 1 2 1 3 Corey K. Gentle, MD , Hemasat Alkhatib, MD , Stephanie A. Valente, DO, FACS , Chao Tu, MS , and Debra A. Pratt, MD, FACS 1 2 Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, OH; Department of Surgery, MetroHealth, Cleveland, OH; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH In a review of metastatic non-breast cancer (https://doi. and subsequent workup revealed no primary breast cancers. org/10.1245/s10434-022-12132-9), 14% of women under- Women with metastatic cancer should not be screened for went screening mammography after stage IV diagnosis, breast cancer given lack of benefit. FUNDING No external sources of funding. DISCLOSURES There are no conflicts of interest to report for any of the authors. Society of Surgical Oncology 2022 Published Online: 2 August 2022 Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. D. A. Pratt, MD, FACS e-mail: deprat@ccf.org

Journal

Annals of Surgical OncologySpringer Journals

Published: Oct 1, 2022

There are no references for this article.